Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Immunomedics Inc (IMMU)

Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Portnoy Law Firm: Tactile Systems Technology, Inc., Pintec Technologies Holdings Limited, and Immunomedics, Inc. Investors Have Limited Amount of Time Before Class Action Deadline Globe NewsWire - Fri Nov 27, 2020

Investors with losses are encouraged to contact Attorney Lesley F. Portnoy.

TCMD : 14.65 (+1.74%)
PT : 1.0800 (unch)
IMMU : 87.86 (+0.05%)
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam Investor Brand Network - Thu Nov 5, 2020

Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced...

PCSA : 1.5300 (-3.16%)
FENC : 9.38 (+0.43%)
IMMU : 87.86 (+0.05%)
Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors Globe NewsWire - Thu Nov 5, 2020

HANOVER, MD, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to...

PCSA : 1.5300 (-3.16%)
FENC : 9.38 (+0.43%)
IMMU : 87.86 (+0.05%)
Gilead Sciences Completes Acquisition of Immunomedics, Inc. Business Wire - Fri Oct 23, 2020

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate.

GILD : 66.95 (+0.28%)
IMMU : 87.86 (+0.05%)
Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma Globe NewsWire - Mon Oct 12, 2020

MORRIS PLAINS, N.J., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug...

IMMU : 87.86 (+0.05%)
Moore Kuehn Encourages IMMU, MOBL, MR, and SCBH Investors to Contact Law Firm Globe NewsWire - Thu Oct 1, 2020

NEW YORK, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

IMMU : 87.86 (+0.05%)
MOBL : 7.04 (+0.07%)
SCBH : 17.2500 (+1.47%)
MR : 5.36 (-1.29%)
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, RST, IMMU, VAR AccessWire - Sat Sep 26, 2020

NEW YORK, NY / ACCESSWIRE / September 26, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of...

GILD : 66.95 (+0.28%)
CBMG : 19.75 (unch)
RST : 29.99 (unch)
IMMU : 87.86 (+0.05%)
VAR : 177.07 (-0.02%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts Globe NewsWire - Tue Sep 22, 2020

WILMINGTON, Del., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

IMMU : 87.86 (+0.05%)
VRTU : 51.33 (+0.03%)
RST : 29.99 (unch)
CBMG : 19.75 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, AKCA, VRTU, IMMU AccessWire - Mon Sep 21, 2020

NEW YORK, NY / ACCESSWIRE / September 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of...

GILD : 66.95 (+0.28%)
CBMG : 19.75 (unch)
AKCA : 18.17 (+0.17%)
VRTU : 51.33 (+0.03%)
IMMU : 87.86 (+0.05%)
Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer Globe NewsWire - Sat Sep 19, 2020

Trodelvy achieves a 27 percent overall response rate and a 5.9-month median duration of response in heavily-pretreated patients with metastatic urothelial cancer (mUC)

IMMU : 87.86 (+0.05%)

Barchart Exclusives

1 Cheap Dividend King With 14% Upside Potential Barchart - Mon Apr 22, 6:30PM CDT
As the energy sector rides out the latest wave of volatility, one undervalued company with a fully integrated business model stands out from the crowd for income-seeking investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot